2.46
-0.22 (-8.21%)
-0.22 (-8.21%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.22 | -8.21% | 2.46 | 15:59:59 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 2.46 | 2.41 | 2.68 | 2.68 | 2.68 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.45 | 2.46 | 0.01 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,593 | 3,909,074 | $ 2.4889 | $ 9,729,317 | 4,459,268 | 0.261 - 10.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:05 | formt | 1,960 | $ 2.45 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.40B | 569.32M | 302.11M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 23.36M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.85 | 3.09 | 2.41 | 2.75 | 3,321,276 | -0.39 | -13.68% |
| 1 Month | 3.40 | 3.87 | 2.41 | 3.02 | 3,263,739 | -0.94 | -27.65% |
| 3 Months | 5.01 | 5.36 | 2.41 | 3.69 | 4,398,562 | -2.55 | -50.9% |
| 6 Months | 2.69 | 10.01 | 2.41 | 4.34 | 6,222,716 | -0.23 | -8.55% |
| 1 Year | 0.31 | 10.01 | 0.261 | 3.29 | 5,236,053 | 2.15 | 693.55% |
| 3 Years | 0.6425 | 10.01 | 0.0552 | 2.96 | 1,981,025 | 1.82 | 282.88% |
| 5 Years | 0.88 | 10.01 | 0.0552 | 2.81 | 1,282,878 | 1.58 | 179.55% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
